Janus Henderson Group’s IRulya Therapeutics IRLA Stock Holding History
Bought
Maintained
Sold
Other funds holding IRLA
SFCM
Janus Henderson Group's IRLA Position: Q3 2026 in Review
Janus Henderson Group opened a new position in IRulya Therapeutics (IRLA) in Q3 2026: 1,714,957 shares worth $53.2M. The stake represents 0.02% of the portfolio and ranks #408 among its holdings.
33 funds tracked by Wall St. Rank hold IRLA as of Q3 2026.
- Janus Henderson Group held 1,714,957 shares of IRulya Therapeutics worth $53.2M as of Q3 2026.
- IRulya Therapeutics was a new Janus Henderson Group position in Q3 2026.
- IRulya Therapeutics made up 0.02% of Janus Henderson Group's portfolio in Q3 2026, its #408 holding.
- 33 funds tracked by Wall St. Rank held IRulya Therapeutics as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.